Murine thrombosis models

Thrombosis and Haemostasis

Volumn 92, Issue REV., 2004, Pages 88-96

  Day, Sharlene M ^a   Reeve, Jennifer L ^a   Myers, Daniel D ^a   Fay, William P ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Animal models; Haemostasis; Mouse or murine; Thrombosis

Indexed keywords

ADRENALIN; COLLAGEN; FERRIC CHLORIDE; ISOFLURANE; KETAMINE; PENTOBARBITAL; ROSE BENGAL; XYLAZINE;

ANESTHESIOLOGICAL TECHNIQUES; ANIMAL MODEL; ARTERY THROMBOSIS; BLOOD EXAMINATION; BLOOD VESSEL INJURY; CELL ASSAY; EXPERIMENTATION; HEMOSTASIS; IN VITRO STUDY; MICROSCOPY; MICROTHROMBUS; MOUSE; NONHUMAN; PHLEBOTOMY; PHOTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION; VEIN THROMBOSIS; VENOUS STASIS;

EID: 12344315198     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Tsakiris DA, Scudder L, Hodivala-Dilke K, et al. Hemostasis in the mouse (mus musculus): a review. Thromb Haemost 1999; 81: 177-88.
2. Hogan KA, Weiler H, Lord ST. Mouse models in coagulation. Thromb Haemost 2002; 87: 563-74.
3. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-80.
4. Farrehi PM, Ozaki CK, Carmeliet P, et al. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 1998; 97: 1002-8.
5. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999; 99: 3050-5.
6. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci 1998; 95: 9524-9.
7. Matsuno H, Uematsu T, Nagashima S, et al. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods 1991; 25: 303-17.
8. Kikuchi S, Umemura K, Kondo K, et al. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimial thickening. Arterioscler Thromb Vasc Biol 1998; 18: 1069-78.
9. Saniabadi AR, Umemura K, Matsumoto N, et al. Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb Haemost 1995; 73: 868-72.
10. Eitzman DT, Westrick RJ, Xu Z, et al. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20: 1831-4.
11. Eitzman DT, Westrick RJ, Nabel EG, et al. Plasminogen activator inhibitor-1 and vitro-nectin promote vascular thrombosis in mice. Blood 2000; 95: 577-80.
12. Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte microparticles are associated with venous thrombogensis. J Vasc Sing 2003; 38: 1075-89.
13. Angelillo-Scherrer A, Garcia de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nature Med 2001; 7: 215-21.
14. Pierangeli SS, Liu XW, Barker JH, et al. Induction of thrombosis in a mouse by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-7.
15. Pierangeli SS, Barker JH, Stikovac D, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994; 71: 670-4.
16. Oury C, Kuijpers MJE, Toth-Zsamboki E, et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 2003; 101: 3969-76.
17. Andre P, Delaney SM, LaRocca T, et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003; 112: 398-406.
18. Rosen ED, Raymond S, Zollman A, et al. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. American Journal of Pathology 2001; 158: 1613-22.
19. Falati S, Gross P, Merrill-Skoloff G, et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nature Med 2002; 8: 1175-80.
20. Carmeliet P, Stassen JM, Schoonjans L, et al. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 1993; 92: 2756-60.
21. Bdeir K, Murciano J-C, Tomaszewski J, et al. Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood 2000; 96: 1820-6.
22. Broze GJ, Jr., Yin Z-F, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost 2001; 85: 747-8.
23. Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci 2000; 97: 2803-8.
24. Peng L, Mundada L, Stomel JM, et al. Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antiox Redox Signal. In press.
25. Kahn M, Zheng Y-W, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
26. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V leiden mutation. Blood 2000; 96: 4222-6.
27. Eitzman DT, Westrick RJ, Bi X, et al. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation 2002; 105: 2139-42.
28. Konstantinides S, Schafer K, Thinnes T, et al. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 2001; 103: 576-83.